and 17/17 p < 0.01, respectively), although no significant amelioration in transaminase levels or volume ratio of necrosis was demonstrated. It could be seen that a moribund state after partial ischemia was accompanied by severe hypoglycemic shock, and that the injection of somatostatin after ischemia or the annihilation of gram-negative bacteria by means of oral administration of polymyxin B before ischemia prevented the occurrence of the hypoglycemic shock.
ischemic liver damage; somatostatin; polymyxin B; endotoxin
The cause of death after severe hepatic damage has not been fully understood.
Normothermic, total, temporary ischemia to the liver for 60-120 min in rats gives rise to necrosis of 10-50% of the total liver area after 24 hr. Although necrosis was found in only 10% of the total area of the liver after 60-90 min ischemia, the 1-week survival rate of the animals was less than 25% (Yamauchi et al. 1981b ). The animal death after ischemic liver damage is therefore the result not only from a certain loss of the hepatocytes but also from the reperfusion of blood to the damaged hepatic tissue.
In the cases of ischemic damage following total ischemia, however, it is possible that the "intact" hepatocytes under an optical microscope may actually be impaired. Animals may die from diffuse hepatic damage depsite of a small amount of manifest necrosis under this condition. An attempt was made to produce partial liver damage by a partial (2/3) ischemia of the middle and left lobes of the liver. In this model one third of the liver, the right and the caudate lobe, remains always intact. In contrast to the total ischemic model the cause of death of the animals can be better assessed in this partial ischemic model. Investigations into metabolic changes and the survival rate of the animals after some therapeutic interventions by means of pancreatic hormones, polymyxin B, and prednisolone are possible, which may suggest the lethal factors after partial ischemia, and it is the purpose of this paper.
MATERIALS AND METHODS
Using Wistar strain male rats weighing 250-370 g, normothermic, temporary, partial ischemia was produced for a period of 60, 90 or 120 min. Under general anesthesia by ether, a laparotomy was performed and the middle and left lobes of the liver were simultaneously pulled out of the abdominal cavity. The portal vein, hepatic artery and the hepatic bile duct of these lobes were occluded by a silk. After 60-120 min of ischemia the occlusion was relieved again (reperfusion).
The animals were sacrificed at 1 or 24 hr after reperfusion to remove blood samples and liver specimens. Metabolic and morphologic parameters such as S-GOT, S-GPT, glucose, immunoreactive insulin (Wilson and Miles 1972) and amino acids in the plasma, the contents of ammonia in the liver and serum, and necrotic areas of the liver were estimated. The Limulus amebocyte lysate (LAL) test was made by the use of Pyrotell.* Each whole blood sample taken without heparin was diluted with pyrogen free water to 100-, 500-and 1000-fold.
To evaluate the survival rate another series of animals were subjected to partial ischemia for 90 min. Therapeutic interventions examined were as follows: Glucagon (1.5 mg/kg), somatostatin (100 pg/kg), or glucose (500 mg/kg) plus insulin (0.3-0.6 U) was injected immediately after reperfusion. Methyl prednisolone (25 mg/kg) was injected before ischemia. Polymyxin B (15 mg/kg) was administered orally for 5-9 days prior to ischemia.
The models of total ischemia or ligation of the portal vein, hepatic artery and bile duct of the middle and left lobes without further reperfusion or 2/3 hepatectomy were produced for comparative studies.
Animals were maintained by 1 ml of saline solution every 30 min during ischemia and reperfusion. All experiments were carried out under a sterile condition . Prior to every experiment 1 mg/kg of heparin sodium was given. 
RESULT
Systemic arterial pressure was maintained satisfactorily during an ischemic procedure except for a period of hypotension (60-80 mm Hg) after reperfusion for 5-10 min.
Portal pressure was elevated by 23±5% (n=3) at 60 min after ischemia. The means and standard deviations of S-GOT and S-GPT after 60, 90 and 120 min ischemia followed by 60 min reperfusion were 1505 ±527, 2366±451 (n=6) ; 1155± 517, 1810±675 (n=7); and 1731±990, 2204±1253 (n=3), respectively.
At 24 hr after 90 min ischemia, the rats demonstrated two typical appearances, normal and moribund. The moribund rats showed little response to the stimulation from the outside and were lethargic. Two of the moribund rats had mean arterial pressures of 110 and 90 mmHg. The plasma levels of S-GOT, S-GPT and glucose, and the necrotic fraction in the liver are illustrated in Table 1 . No significant differences in S-GOT, S-GPT or necrotic density were observed between the normal and moribund states. However, the glucose level was significantly decreased in the moribund state after either partial or total ischemia. TABLE 1. Levels of S-GOT, S-GPT, blood glucose and necrotic fraction at 24 hr after partial (2/3) and total (3/3) temporary ischemia The plasma levels of insulin, ammonia and amino acids 24 hr after ischemia are listed in Table 2 . The total amount of amino acids in the plasma was increased at a significance level of 1 percent, but no decrease was revealed in the molar ratio. The plasma levels of glutamine+glutamate, threonine and methionine tended to increase; while in the liver, aspartate+asparagine increased and valine, isoleucine, leucine and phenylalanine decreased. Table 3 summarizes the results of the Limulus test. Portal vein blood from 1 control case showed a 3-plus Limulus test. Except for only 1 case of negative Limulus test after 2/3 partial ischemia for 90 min, all other animals that underwent partial or total ischemia showed a 3-plus Limulus test. On the other hand, blood of the animals treated with polymyxin B before ischemia presented neither 2-nor 3-plus Limulus test in the acute state. Five to 9 times of polymyxin B administration made gram-negative bacteria in the feces of the animals very scarce. All the blood from the animals in a moribund state demonstrated a 3-plus Limulus test.
The results of S-GOT, S-GPT and necrotic fraction after the therapeutic interventions are presented in Table 4 together with those after a 2/3 ligation. No significant differences were found between the values of partial ischemia with normal appearance and those after therapeutic interventions. On the other hand, remarkable rises in the levels of S-GOT, and S-GPT with 100% of necrotic density were indicated in the group of 2/3 ligation.
Survival rates of the animals are demonstrated in Table 5 . Each value was compared with the corresponding survival rate after partial ischemia without a therapeutic intervention (control). The statistical levels were tested by the x2 test with Yates' correction. After 90 min of partial ischemia, about 40% of the animals died within 2 days, and 8% died 3 to 7 days after ischemia. Most of the animals that died 3 to 7 days after ischemia had multiple liver abscesses and showed a marked loss of body weight. Hyperbilirubinemia (3 rats), pneumonia (2 rats) and ascites (1 rat) were also noted. The polymyxin B treatment and TABLE 4 . Levels of S-GOT, S-GPT, blood glucose and nectoric function at 24 hr after partial ischemia with some therapeutic interventions 
DISCUSSION
For death of the animals later than 3 days after ischemia, a remarkable infection may be responsible. Death in an early stage within 48 hr is under discussion. Two-thirds hepatectomy never killed the animals, and only a few animals died after the partial ligation of the portal vein and hepatic artery together with the bile duct of the middle and left lobes. Therefore, it could be seen that "reperfusion" of the partial necrotic liver decreases the survival. 3-plus Limulus tests were frequently observed in the blood immediately after partial or total ischemia or of chronic moribund rats.
Furthermore, there were no animals deaths nor 3-plus Limulus tests after oral administration of polymyxin B.
These findings lead to the view that the hypoglycemia after ischemia is induced by endotoxemia. The glucose levels in endotoxin shock may be variable with the stage of the shock and the grade of toxicity. In the severe state of endotoxin shock including the terminal period, hypoglycemia could be observed (Beck et al. Seventy-five percent of the animals died within 24 hr after partial ischemia with an injection of glucose and insulin. This can be interpreted merely as a result from relatively high doses of insulin which accelerate the hypoglycemia. Provided the glucose levels are continuously maintained, with or without insulin, a favorable effect of the glucose on the survival rate can be expected as demonstrated by Hinshaw et al. (1974) and McDougal et al. (1978) .
Glucagon has been utilized to improve metabolic and circulatory abnormalities in hemorrhagic shock (Schumer et al. 1973; Lindberg et al. 1978) . The high doses of glucagon for the normal control rats caused a conspicuous hyperglycemia for more than 6 hr with its peak at 3 to 4 hr after injection. The increase ratio of the blood glucose level 3 hr after injection was 200+42% (n=3). The significant rise in 1-to 2-days survival rates may be related to the augmented glucose level.
After high doses of somatostatin injection a statistically significant rise in 1-to 7-days survival rates was observed. It has been known that somatostatin depresses both insulin and glucagon secretion (MV rki et al. 1979) , although its analogues selectively inhibit insulin secretion (Lien and Garsky 1978; Taborsky et al. 1979 ). In our present study, its injection to the normal control animals caused a significant elevation of the glucose level with the peak at 3 hr after the injection (145±7%, n=3). It could be, therefore, said that the increasing glucose level as observed after glucagon injection may be implicated in the effect of somatostatin on the 1-to 2-days survival rate after ischemia. The beneficial effect on the 3-to 7-days survival rates, however, needs further investigation. The profitable effect of this hormone on the regeneration of the hepatocytes and the hepatic blood flow is to be taken into account (Goldman 1978) .
Prednisolone mitigates an unfavorable effect of endotoxin on the liver, such as uncoupling of mitochondria (DePalma et al. 1977) . It improves also remarkably the morphological abnormalities of mitochondria after experimental bile duct ligation of the rat which seem to be due partly to endotoxemia (Yamauchi et al. 1981a ). Moreover, corticosteroids have been used for patients with shock, since they effectively lower the levels of lactate and amino acids which can be used as substrates for gluconeogenesis (Schumer and Nyhus 1970) . Although no statistically significant elevation of survival rate was confirmed, the previous literature gives a rationale to use glucocorticoids in ischemic liver damage.
Polymyxin B has been found to be effective to annihilate gram-negative bacteria and has been actually used for liver diseases (Liehr 1975; Wilkinson et al. 1976 ). The rabbits subjected to an intestinal sterilization by means of oral administration of polymyxin B survived after 90 min of partial ischemia of the liver, while a high mortality rate was observed without the treatment with polymyxin B (Raute-Kreinsen et al. 1980). The results of the present study support this previous report.
Maintenance of the glucose level, annihilation of gram-negative bacteria, and supplementary use of glucagon and/or somatostatin are recommendable for the treatment of ischemic liver damage.
